Cameron Kim

Cameron Kim is Assistant Professor of the Practice in Biomedical Engineering (BME) at Duke University and Associate Director of Undergraduate Studies in BME. He also holds appointments as Associate Faculty in the Duke Science & Society Initiative and as a member of the Duke Center for Advanced Genomic Technologies. Kim’s research focuses on engineering education in synthetic biology, mentoring students in molecular and cellular engineering, design thinking, and team-based problem solving to address novel challenges in gene and cell-based therapies. He serves as the research advisor for the Duke International Genetically Engineered Machine (iGEM) team, guiding students in responsible innovation and ethics-guided design of emerging biotechnologies. Kim’s educational scholarship centers on cultivating character, ethical reasoning, and professional formation in engineering students, culminating in the Duke BME “Ethics Everywhere” model of integrating ethics and values into technical training. He earned his Ph.D. in Bioengineering at Stanford University, where his research focused on RNA engineering in mammalian synthetic biology.

Immuno US 2023

Featuring 30+ presentations, the event brings together over 120 attendees from leading pharma, biotech and academic organisations designing innovative strategies and technologies for more effective cancer immunotherapy development.

Expand your knowledge & discuss future priorities in:

Discovery & Development: Cell Therapies & Antibody Approaches
Biomarkers, Precision Medicine & Spatial Biology in Immuno-Oncology
Discovery & Development: Intra-tumoral Immuno & Combination Therapies & Small Molecules as IO Therapies
Translational & Preclinical and Clinical Development

View the agenda here – https://www.oxfordglobal.co.uk/immuno-series-us/agenda/?utm_source=ebrc&utm_medium=eventlisting&utm_campaign=immuno&utm_content=immunous2023

Co-located with Biomarkers US 2023 attendees receive access to both events. For more information contact marketing@oxfordglobal.co.uk

Targets and Cell Types in Immuno-Oncology Europe 2023

With new & emerging targets and drug candidates in immuno-oncology, key opinion leaders from pharmaceutical & biotech companies as well as academic & research organisations will be presenting on innovative approaches & methods for target identification & validation, such as AI-based strategies, novel checkpoint inhibitors and latest developments & case studies in cellular therapies : TILs, gamma deltas, myeloid cells.

Expand your knowledge & discuss future priorities in:
– Emerging Technologies, Strategies & Methods for Novel Targets & Target Validation in Immuno-Oncology
– Novel Cell Types to Develop Effective IO Therapies

View the agenda:https://www.oxfordglobal.co.uk/immuno-targets-cells/agenda/?utm_source=ebrc&utm_medium=eventlisting&utm_campaign=immuno&utm_content=tacell2023

Co-located with Biomarkers Europe 2023 and Precision Oncology Europe 2023, attendees will receive access to all three events. For more information contact marketing@oxfordglobal.co.uk

RNA Therapeutics & Delivery 2023

Join RNA leaders, experts and distinguished scientists in Europe, delivering breakthrough research, technologies & connecting global pharma, biotech and academia for high-level discussions on the latest innovations within the formulation and delivery of RNA-based therapeutics.

Formulation & Drug Delivery US 2023

Join leaders, experts and researchers at West Coast’s scientific Hub – San Diego, delivering breakthrough research, technologies & connecting global pharma, biotech and academia for high-level discussions on the latest innovations in formulation, drug delivery & inhaled science

Spatial Biology Europe 2023

Explore spatial research: from the application of spatial technologies in biology through to topical updates from spatial genomics, transcriptomics, metabolomics and spatial bioinformatics.

Expand your knowledge and discuss future priorities in:
– Spatial Multi Omics Techniques & Approaches
– Applications of Spatial Research & Technologies in Biology
– Spatial Biology in Pharma & Translational Drug Research
– Spatial Bioinformatics, Data Analysis and Interpretation

Benefits to attending include:
– Learn from Applications on Therapeutic Areas – Case Studies on Cardiovascular Development, Oncology, Neurobiology
– Explore the latest Spatial Technologies and Overcome Challenges in the Adoption of Translational Drug Research
– Gain insights into Spatial Multi-Omics applications for thr Tumor micro-environment
& much more!

View the agenda here: https://www.oxfordglobal.co.uk/spatial-biology-europe/agenda/download-agenda/?utm_source=ebrc&utm_medium=eventlisting&utm_campaign=omics&utm_content=sanaeu2023

NextGen Omics 2023

NextGen Omics 2023 features 4 outstanding programmes, bringing together Europe’s most successful omics research experts under one roof. The series provides an excellent networking platform which consists of key discussion topics in: Next Generation Sequencing & Clinical Diagnostics, Single Cell & Spatial Analysis, Synthetic Biology in Discovery & Therapeutics and Digital PCR & Liquid Biopsies.

Expand your knowledge and discuss future priorities at:
– NGS & Clinical Diagnostic Congress – https://www.oxfordglobal.co.uk/nextgen-omics-series-uk/ngs-clinical-diagnostics/
– Single Cell & Spatial Analysis Congress – https://www.oxfordglobal.co.uk/nextgen-omics-series-uk/single-cell/
– Synthetic Biology in Drug Discovery & Therapeutics Congress – https://www.oxfordglobal.co.uk/nextgen-omics-series-uk/synthetic-biology/
– Digital PCR & Liquid Biopsies Congress – https://www.oxfordglobal.co.uk/nextgen-omics-series-uk/digital-pcr/

The event also features the NextGen Omics Young Scientist Awards including the best poster presentation award and are intended to honour an outstanding individual performance for a scientific work by a PhD student, PostDoc or early career scientist. – https://www.oxfordglobal.co.uk/nextgen-omics-series-uk/young-scientist/

View the full agenda here: https://www.oxfordglobal.co.uk/nextgen-omics-series-uk/agenda/download-agenda/?utm_source=ebrc&utm_medium=eventlisting&utm_campaign=omics&utm_content=ngsuk2023

Request for Information on Developing a Roadmap for the TIP Directorate at the National Science Foundation

Publication Date: July 2023

EBRC’s response to the request by the NSF for comments on the development of a roadmap to guide investment decisions of the newly formed TIP Directorate. We recommend prioritizing engineering biology research through infrastructure development, data programs, and equitable workforce initiatives to strengthen biotechnology translation and U.S. economic competitiveness. We also highlight the several crosscutting areas for investments where engineering biology overlaps with other TIP areas of interest, such as AI, materials science, climate change, and advanced robotics.